Validamycin D
CAS: 12650-67-8
Ref. 3D-MAA65067
| 5mg | 1,770.00 € | ||
| 10mg | 2,832.00 € | ||
| 25mg | 5,309.00 € | ||
| 50mg | 8,495.00 € |
Product Information
Validamycin D is an inhibitor of kinases that has shown potential for use in cancer treatment. It is a potent analog of the Chinese traditional medicine compound validamycin A, which has been used as an anticancer agent for many years. Validamycin D has been shown to inhibit the growth of human cancer cells and induce apoptosis, or programmed cell death, in tumor cells. It is also a toxin to some extent and can be detected in urine after administration. This drug targets specific proteins involved in cell signaling pathways and inhibits their activity, leading to reduced cell proliferation and tumor growth. Validamycin D has great potential as a new class of anticancer agents due to its unique mechanism of action and promising preclinical data.
Chemical properties
Technical inquiry about: 3D-MAA65067 Validamycin D
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
